Jawed Fareed

21.3k total citations · 1 hit paper
784 papers, 12.5k citations indexed

About

Jawed Fareed is a scholar working on Internal Medicine, Surgery and Hematology. According to data from OpenAlex, Jawed Fareed has authored 784 papers receiving a total of 12.5k indexed citations (citations by other indexed papers that have themselves been cited), including 287 papers in Internal Medicine, 286 papers in Surgery and 268 papers in Hematology. Recurrent topics in Jawed Fareed's work include Venous Thromboembolism Diagnosis and Management (287 papers), Heparin-Induced Thrombocytopenia and Thrombosis (218 papers) and Blood Coagulation and Thrombosis Mechanisms (163 papers). Jawed Fareed is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (287 papers), Heparin-Induced Thrombocytopenia and Thrombosis (218 papers) and Blood Coagulation and Thrombosis Mechanisms (163 papers). Jawed Fareed collaborates with scholars based in United States, Germany and France. Jawed Fareed's co-authors include Jeanine M. Walenga, Debra Hoppensteadt, Walter Jeske, Debra A. Hoppensteadt, Omer Iqbal, Harry L. Messmore, Rodger L. Bick, Robert J. Linhardt, Bruce Lewis and J Choay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of Clinical Oncology.

In The Last Decade

Jawed Fareed

748 papers receiving 11.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia

2001 507 citations Bruce Lewis, Jawed Fareed et al. profile →

Peers

Countries citing papers authored by Jawed Fareed

Since Specialization

Citations

This map shows the geographic impact of Jawed Fareed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jawed Fareed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jawed Fareed more than expected).

Fields of papers citing papers by Jawed Fareed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jawed Fareed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jawed Fareed. The network helps show where Jawed Fareed may publish in the future.

Co-authorship network of co-authors of Jawed Fareed

This figure shows the co-authorship network connecting the top 25 collaborators of Jawed Fareed. A scholar is included among the top collaborators of Jawed Fareed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jawed Fareed. Jawed Fareed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment with Sulodexide Downregulates Biomarkers for Endothelial Dysfunction in Convalescent COVID-19 Patients 2025 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), (unknown), (unknown), Jawed Fareed	1
2	Endogenous Dysregulation of Thromboinflammatory Biomarkers in End-Stage Renal Disease, and Their Amplification by Heart Failure 2024 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), Vinod Bansal, Fakiha Siddiqui, (unknown), Debra Hoppensteadt, (unknown), (unknown), (unknown), Jawed Fareed, Mushabbar Syed	1
3	Thromboinflammatory Biomarkers of Cardiorenal Syndrome in Patients With End-Stage Renal Disease 2024 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), (unknown), Debra Hoppensteadt, Fakiha Siddiqui, Jawed Fareed, Vinod Bansal	0
4	Charlson and Elixhauser Comorbidity Indices for Prediction of Mortality and Hospital Readmission in Patients With Acute Pulmonary Embolism 2024 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jawed Fareed, Amir Darki	0
5	Vascular Endothelial Dysfunction and Immunothrombosis in the Pathogenesis of Atrial Fibrillation 2024 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), (unknown), (unknown), Debra Hoppensteadt, Fakiha Siddiqui, Luís Augusto Rohde, Jawed Fareed, Mushabbar Syed	2
6	Interrelationship Between Inflammatory Biomarkers and Collagen Remodeling Proteins in Atrial Fibrillation 2023 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), (unknown), Debra Hoppensteadt, Fakiha Siddiqui, (unknown), Amir Darki, Jawed Fareed, Mushabbar Syed	5
7	Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro-Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary Embolism 2023 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), (unknown), Amir Darki, Fakiha Siddiqui, Debra Hoppensteadt, Jeanine M. Walenga, Jawed Fareed, (unknown)	4
8	The Relevance of Thrombo-Inflammatory Biomarkers and Their Relationship with Circulating Glycosaminoglycans in End-Stage Renal Disease Patients 2023 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), Vinod Bansal, Fakiha Siddiqui, Debra Hoppensteadt, (unknown), Jawed Fareed, (unknown)	3
9	The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients 2022 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), Amir Darki, Fakiha Siddiqui, Debra Hoppensteadt, (unknown), Roland Krämer, Cafer Adıgüzel, Jawed Fareed	3
10	Endogenous Glycosaminoglycans in Various Pathologic Plasma Samples as Measured by a Fluorescent Quenching Method 2022 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), (unknown), (unknown), Fakiha Siddiqui, (unknown), Debra Hoppensteadt, Vinod Bansal, Amir Darki, David H. Van Thiel, Jawed Fareed	3
11	Cellular Indices and Outcome in Patients with Acute Venous Thromboembolism 2022 ·Clinical and Applied Thrombosis/Hemostasis ·Fakiha Siddiqui, Alberto García‐Ortega, (unknown), James Sinacore, Alfonso Tafur, Pablo Demelo‐Rodríguez, (unknown), Esther Usandizaga, Jawed Fareed, Manuel Monréal, (unknown)	10
12	Application of Rotational Thromboelastometry in Patients with Acute Promyelocytic Leukemia 2022 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), (unknown), Marijana Virijević, Zoran Bukumirić, (unknown), (unknown), (unknown), Ana Vidović, Nada Suvajdžić, (unknown), Jawed Fareed, Darko Antić, Mirjana Mitrović	7
13	Elevated salivary cortisol predicts response to adjunctive immune modulation in treatment-resistant bipolar depression 2021 ·Journal of Affective Disorders Reports ·Stephen Murata, Michael Murphy, (unknown), Debra Hoppensteadt, Jawed Fareed, Angelos Halaris	3
14	Interrelationship of MMP-9, Proteoglycan-4, and Inflammation in Osteoarthritis Patients Undergoing Total Hip Arthroplasty 2021 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), (unknown), Pavel Poredoš, Peter Poredoš, Mateja K. Ježovnik, Debra Hoppensteadt, Jawed Fareed, William Hopkinson	19
15	An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination 2021 ·Clinical and Applied Thrombosis/Hemostasis ·(unknown), Omer Iqbal, Jeanine M. Walenga, Bruce Lewis, (unknown), Charles A. Carter, Meharvan Singh, Fabio Lievano, Alfonso Tafur, Eduardo Ramacciotti, Grigoris Gerotziafas, Walter Jeske, Jawed Fareed	33
16	Urinary Prothrombin Fragment 1 + 2 as an Endogenous Marker of Venous Thromboembolism 2019 ·(unknown), Walter Jeske, Ola E. Dahl, Jawed Fareed, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
17	Systematic analysis of enoxaparins from different sources with online one- and two-dimensional chromatography 2019 ·The Analyst ·Yilan Ouyang, Meng Zhu, Xin Wang, Yi Lin, Jawed Fareed, Robert J. Linhardt, Zhenqing Zhang	9
18	Synthetic oligosaccharides can replace animal-sourced low–molecular weight heparins 2017 ·Science Translational Medicine ·Yongmei Xu, Kasemsiri Chandarajoti, Xing Zhang, Vijayakanth Pagadala, Wenfang Dou, Debra Hoppensteadt, Erica Sparkenbaugh, Brian C. Cooley, (unknown), Nigel S. Key, (unknown), Jawed Fareed, Robert J. Linhardt, Rafał Pawliński, Jian Liu	87
19	Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period 2006 ·Clinical and Applied Thrombosis/Hemostasis ·Steven R. Deitcher, Craig M. Kessler, Geno J. Merli, James R. Rigas, Roger M. Lyons, Jawed Fareed	294
20	Treatment with the novel anti-angiogenic agent PI-88 is associated with immune-mediated thrombocytopenia 2002 ·Annals of Oncology ·Mark Rosenthal, Danny Rischin, Grant A. McArthur, Karen Ribbons, Beng H. Chong, Jawed Fareed, Guy C. Toner, M. D. Green, R. Basser	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact